Insider Transactions in Q1 2022 at Global Blood Therapeutics, Inc. (GBT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2022
|
Alexis A. Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,400
+50.0%
|
-
|
|
Mar 01
2022
|
Ted W Love President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,074
-0.51%
|
$118,146
$29.87 P/Share
|
|
Mar 01
2022
|
Ted W Love President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,445
+1.17%
|
-
|
|
Mar 01
2022
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,315
-4.58%
|
$38,135
$29.87 P/Share
|
|
Mar 01
2022
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,763
+8.77%
|
-
|
|
Mar 01
2022
|
Jung Choi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
956
-0.5%
|
$27,724
$29.87 P/Share
|
|
Mar 01
2022
|
Jung Choi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,763
+1.42%
|
-
|
|
Mar 01
2022
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
956
-2.61%
|
$27,724
$29.87 P/Share
|
|
Mar 01
2022
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,763
+7.02%
|
-
|
|
Mar 01
2022
|
Nazila Habibizad Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-2.07%
|
$17,777
$29.87 P/Share
|
|
Mar 01
2022
|
Nazila Habibizad Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,671
+5.34%
|
-
|
|
Mar 01
2022
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
956
-2.06%
|
$27,724
$29.87 P/Share
|
|
Mar 01
2022
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,763
+5.61%
|
-
|
|
Feb 28
2022
|
Ted W Love President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
839
+0.11%
|
$20,975
$25.37 P/Share
|
|
Feb 28
2022
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
453
+1.32%
|
$11,325
$25.37 P/Share
|
|
Feb 28
2022
|
David Lee Johnson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
472
+1.07%
|
$11,800
$25.37 P/Share
|
|
Feb 01
2022
|
Jung Choi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,340
-1.73%
|
$96,860
$29.33 P/Share
|
|
Feb 01
2022
|
Jung Choi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,020
+4.47%
|
-
|
|
Feb 01
2022
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,559
-5.58%
|
$74,211
$29.33 P/Share
|
|
Feb 01
2022
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,770
+12.87%
|
-
|
|
Feb 01
2022
|
Ted W Love President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,531
-1.32%
|
$305,399
$29.33 P/Share
|
|
Feb 01
2022
|
Ted W Love President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,955
+3.61%
|
-
|
|
Feb 01
2022
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,506
-14.78%
|
$130,674
$29.33 P/Share
|
|
Feb 01
2022
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,020
+22.84%
|
-
|
|
Feb 01
2022
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,470
-9.41%
|
$100,630
$29.33 P/Share
|
|
Feb 01
2022
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,395
+20.31%
|
-
|